Trending Topic

Moderna Resolve

Automatically clustered newsroom coverage around one of the most active themes in the intellectual property ecosystem.

GSK and Moderna Resolve Patent Litigation Over COVID-19 and RSV Vaccine Technologies
PatentsUSA

GSK and Moderna Resolve Patent Litigation Over COVID-19 and RSV Vaccine Technologies

GlaxoSmithKline (GSK) and Moderna have settled patent infringement lawsuits concerning Moderna’s COVID-19 vaccines Spikevax and mNEXSPIKE, as well as its RSV vaccine mResvia. The resolution includes cross-licensing agreements covering infectious disease technologies and dismissal of US claims with prejudice, allowing…

Friday, November 6, 2026
Newsletters & Digests

Follow Moderna Resolve

Subscribe to receive daily and weekly newsroom coverage aligned to this trend cluster and adjacent IP developments.

Choose your regions
Choose your categories
By subscribing, you agree to receive IIPLA newsroom emails. You can update preferences or unsubscribe anytime.
Explore
All coverageFiltered archive